New VR program helps users face social situations with confidence

Oxford VR, a U.K.-based virtual reality (VR) technology company, has launched an automated mental health program aimed at helping users overcome anxious social avoidance. This new intervention, known as social engagement, was designed to help patients with agoraphobia, panic disorder, social anxiety, depression, schizophrenia and other common mental health conditions.

The program was developed by Oxford VR specialists and builds on years of work carried out by Oxford University researchers. Users participate in half-hour sessions each week, putting on a VR headset and interacting with a “virtual world where they are guided by a virtual coach and required to complete a series of graded tasks.” Sessions will take participants through walking down a busy street, riding a public bus, shopping and other common activities known to be affected by feelings of anxious social avoidance.

As the program continues, users will be asked to overcome “problematic situations” as they interact with “life-like, interactive and engaging” environments.

“Our vision is to turn the tide on life-interrupting mental illnesses pushing the boundaries of clinical excellence and new technology to transform lives,” June Dent, director of clinical partnerships for Oxford VR, said in a prepared statement. “The immersive nature of VR provides a powerful new way to engage users and helps them to regain confidence, feel safe and overcome trigger situations. This innovative program has been created with the voices and expertise of people affected by anxious social avoidance and applies proven evidence-based psychological techniques.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”